Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Expert Opinion on Therapeutic Patents
|
November 5, 2015
Amorfrutins are efficient modulators of peroxisome proliferator-activated receptor gamma (PPARγ) with potent antidiabetic and anticancer properties: a patent evaluation of WO2014177593 A1
Antonio Lavecchia, Carmen Di Giovanni
Biomolecules
|
February 27, 2026
Nuclear Receptor-Targeted Therapies: Reprogramming Metabolism with TRβ, ERRα, and LXR Modulators
Carmen Di Giovanni, Antonio Lavecchia
European Biophysics Journal : EBJ
|
February 1, 2012
Conformational switch of a flexible loop in human laminin receptor determines laminin-1 interaction
Carmen Di Giovanni, Alessandro Grottesi, Antonio Lavecchia
Expert Opinion on Therapeutic Patents
|
February 20, 2010
Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review
Antonio Lavecchia, Carmen Di Giovanni, Ettore Novellino
Expert Opinion on Therapeutic Patents
|
January 18, 2014
Novel inhibitors of signal transducer and activator of transcription 3 signaling pathway: an update on the recent patent literature
Antonio Lavecchia, Carmen Di Giovanni, Carmen Cerchia
Current Medicinal Chemistry
|
May 16, 2009
CDC25A and B dual-specificity phosphatase inhibitors: potential agents for cancer therapy
Antonio Lavecchia, Carmen Di Giovanni, Ettore Novellino
Pharmacological Research
|
September 27, 2005
Cosmetovigilance survey: are cosmetics considered safe by consumers?
Carmen Di Giovanni, Vincenzo Arcoraci, Loredana Gambardella, et al.
Biomedical Chromatography : BMC
|
May 26, 2005
Determination of cymoxanil in drinking water and soil using high-performance liquid chromatography
Paola Fidente, Carmen Di Giovanni, Serenella Seccia, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
December 17, 2008
Cdc25B phosphatase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective
Antonio Lavecchia, Antonio Coluccia, Carmen Di Giovanni, et al.
Expert Opinion on Investigational Drugs
|
September 9, 2016
Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016)
Carmen Di Giovanni, Ettore Novellino, Adriana Chilin, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Expert Opinion on Therapeutic Patents
|
November 5, 2015
Amorfrutins are efficient modulators of peroxisome proliferator-activated receptor gamma (PPARγ) with potent antidiabetic and anticancer properties: a patent evaluation of WO2014177593 A1
Antonio Lavecchia, Carmen Di Giovanni
Biomolecules
|
February 27, 2026
Nuclear Receptor-Targeted Therapies: Reprogramming Metabolism with TRβ, ERRα, and LXR Modulators
Carmen Di Giovanni, Antonio Lavecchia
European Biophysics Journal : EBJ
|
February 1, 2012
Conformational switch of a flexible loop in human laminin receptor determines laminin-1 interaction
Carmen Di Giovanni, Alessandro Grottesi, Antonio Lavecchia
Expert Opinion on Therapeutic Patents
|
February 20, 2010
Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review
Antonio Lavecchia, Carmen Di Giovanni, Ettore Novellino
Expert Opinion on Therapeutic Patents
|
January 18, 2014
Novel inhibitors of signal transducer and activator of transcription 3 signaling pathway: an update on the recent patent literature
Antonio Lavecchia, Carmen Di Giovanni, Carmen Cerchia
Current Medicinal Chemistry
|
May 16, 2009
CDC25A and B dual-specificity phosphatase inhibitors: potential agents for cancer therapy
Antonio Lavecchia, Carmen Di Giovanni, Ettore Novellino
Pharmacological Research
|
September 27, 2005
Cosmetovigilance survey: are cosmetics considered safe by consumers?
Carmen Di Giovanni, Vincenzo Arcoraci, Loredana Gambardella, et al.
Biomedical Chromatography : BMC
|
May 26, 2005
Determination of cymoxanil in drinking water and soil using high-performance liquid chromatography
Paola Fidente, Carmen Di Giovanni, Serenella Seccia, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
December 17, 2008
Cdc25B phosphatase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective
Antonio Lavecchia, Antonio Coluccia, Carmen Di Giovanni, et al.
Expert Opinion on Investigational Drugs
|
September 9, 2016
Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016)
Carmen Di Giovanni, Ettore Novellino, Adriana Chilin, et al.
Page
of 4